Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

Elastomeric Infusion Pumps Market Trends

The global elastomeric infusion pumps market size was estimated at USD 637.4 million in 2023 and is projected to grow at a CAGR of 7.1 % from 2024 to 2030. The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a significant driver for the market growth. According to statistics from the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for 71% of all deaths globally. This led to a higher demand for continuous drug delivery systems such as elastomeric pumps to ensure effective treatment and management of these conditions.

The growing demand for home healthcare solutions is a crucial factor driving the elastomeric infusion pumps market. Patients prefer therapies that enable them to administer medications at home, and the portability and user-friendliness of elastomeric pumps cater to this need. This trend is amplified by the aging population's increasing requirement for long-term treatment of chronic conditions. According to a study published in October 2024, Osteomyelitis affects around 50,000 people annually in the U.S., with higher incidence in children, older adults, and males. Vertebrae and long bones are the most commonly involved sites. It also shows that males are more susceptible to Osteomyelitis than females, as evidenced by the current research and other published data on the disease.

Manufacturers are focusing on enhancing elastomeric infusion pump technologies to drive market growth. These advancements involve greater accuracy, longer infusion durations, developing pumps with improved features, and accessible designs. These innovations aim to cater to the diverse needs of patients and healthcare providers, enhancing the efficiency of elastomeric infusion pumps and making them dependable and secure. For instance, elastomeric infusion pumps can deliver continuous infusions of analgesics, chemotherapy, and cardiology treatments safely and accurately without needing a power source by utilizing pressure generated by an elastomeric balloon.

Product Insights

The continuous rate elastomeric infusion pumps segment dominated the market and accounted for a revenue share of 59.3% in 2023 as these pumps provide a steady, controlled flow of medications, making them well-suited for treatments that necessitate constant and regulated drug delivery, such as antibiotic therapies and pain management. Their simplicity and operational efficiency made them a preferred choice across various healthcare settings, driving their significant market share. For instance, in April 2024, Baxter International Inc. established new-era elastomeric infusion pumps featuring improved durability and accessible designs, further strengthening its position as a provider of infusion therapy solutions. The continuous rate pumps are extensively utilized in hospitals and home healthcare settings due to their dependability and simplicity of use, which fuels their demand and drives market expansion.

The variable rate elastomeric infusion pumps segment is the fastest-growing category within the market. These pumps can deliver medications at varying flow rates, making them well-suited for applications that require more complex or customized infusion profiles, such as pain management, chemotherapy, and antibiotic/antiviral treatments. The increasing demand for flexible and personalized drug delivery solutions is a crucial driver fuelling the rapid expansion of the variable rate elastomeric pumps segment.

Application Insights

The pain management segment held the largest revenue share of 37.6% in 2023. The increasing prevalence of chronic pain conditions globally, leading to a growing demand for effective pain management solutions. Additionally, the rising geriatric population prone to various chronic illnesses requiring pain management contributes significantly to the market growth in this segment. Elastomeric infusion pumps are widely used to manage pain in acute and chronic settings, enabling patients to self-administer medications as needed and providing effective and convenient pain relief. For instance, a study published in the Journal of Pain Research in 2022 found that using elastomeric infusion pumps for post-operative pain management improved patient satisfaction and reduced opioid consumption, highlighting the growing preference for these devices in pain management applications.

The antibiotic/antiviral therapy segment is the fastest-growing application segment within the elastomeric infusion pumps market. The rising prevalence of infectious diseases and the growing need for effective and convenient delivery of antibiotics and antiviral medications drive the demand for elastomeric pumps in this segment. For instance, a study published in the Journal of Antimicrobial Chemotherapy in 2023 found that using elastomeric infusion pumps for continuous infusion of antibiotics in critically ill patients improved clinical outcomes and reduced antibiotic resistance, highlighting their utility in combating severe infections. 

End Use Insights

The hospitals segment accounts for the largest revenue share of 43.5% in the elastomeric infusion pumps market in 2023. This dominance can be attributed to the widespread adoption of these pumps in various hospital settings, such as surgical wards, intensive care units, and oncology departments. Hospitals require reliable and accurate drug delivery solutions to manage diverse patient needs, from post-operative pain management to chemotherapy administration. Elastomeric infusion pumps are well-suited for these applications, as they offer consistent medication delivery, ease of use, and reduced risk of medication errors compared to traditional IV infusion methods.

The ambulatory surgical centers (ASCs) segment is the fastest-growing application in the elastomeric infusion pumps market. The increasing shift towards outpatient surgical procedures and the growing preference for minimally invasive surgeries drive the adoption of elastomeric pumps in ASCs. These pumps provide a convenient and cost-effective solution for delivering continuous infusions of pain medications and antibiotics to patients following same-day surgeries, enabling faster recovery and reducing hospital burden. According to the National Library of Medicine data published in 2023, using elastomeric pumps for post-operative pain management in ASCs improved patient satisfaction and reduced opioid consumption, highlighting their utility in enhancing patient outcomes and experience in outpatient surgical settings. 

Regional Insights

In North America, the elastomeric infusion pump market is witnessing significant growth driven by the increasing prevalence of chronic diseases, rising demand for home healthcare services, and technological advancements. The region has a well-established healthcare infrastructure, and favorable reimbursement policies further contribute to the market expansion. Moreover, the growing geriatric population in North America is boosting the demand for infusion pumps, including elastomeric pumps.

U.S. Elastomeric Infusion Pumps Market Trends

The U.S. is a significant contributor to the growth of the elastomeric infusion pumps market, driven by the country's robust healthcare infrastructure, favorable reimbursement policies, and the presence of key market players. The U.S. Food and Drug Administration (FDA) implemented stringent regulations to ensure the safety and efficacy of infusion pumps, which led to the development of innovative products with advanced features. Additionally, the increasing prevalence of chronic diseases, the growing trend towards home-based healthcare solutions, and the rising number of surgical procedures fuel the demand for elastomeric infusion pumps in the U.S. 

Europe Elastomeric Infusion Pumps Market Trends

 In Europe, the elastomeric infusion pump market is experiencing steady growth supported by factors such as a rising geriatric population, increasing prevalence of chronic diseases, and favorable healthcare policies. According to the European Union's (EU) estimates, the EU population was 448.8 million people, with more than one-fifth (21.3%) of the population aged 65 years and older. The region boasts a well-established healthcare system with high adoption rates of advanced medical technologies. Regulatory bodies including the European Medicines Agency (EMA) ensure strict compliance with quality standards for medical devices, including infusion pumps.

Asia Pacific Elastomeric Infusion Pumps Market Trends

The Asia Pacific region presents immense growth opportunities for the elastomeric infusion pumps market due to rapidly expanding healthcare infrastructure, increasing disposable income levels, and growing awareness about advanced medical treatments. Manufacturers are also tapping into the expansion of the healthcare market in emerging economies of China and India, where improving access to medical technologies is supporting the adoption of advanced solutions such as smart elastomeric pumps with features including remote monitoring.

Key Companies & Market Share Insights

Key strategies employed by companies to enhance their market position include organic growth initiatives such as new product launches, geographical expansion, and collaborations with healthcare providers. Inorganic growth strategies such as mergers, acquisitions, and partnerships are common among key players to strengthen their market presence and expand their product offerings.

Recent Developments

• In January 2024, the East and North Hertfordshire NHS Trust launched a new elastomeric pump pathway for hospital-at-home patients, enabling nurses to deliver antibiotic medications with just one daily visit, reducing the number of required nursing visits by half.

• In October 2023, China's National Medical Product Administration (NMPA) approved 221 medical device products, including 176 domestic Class III devices, 28 imported Class III devices, 16 imported Class II devices, and one from Hong Kong, Macau, or Taiwan. This diversification of approved products signals a growing medical device ecosystem in China.

• In January 2022, ICU Medical acquired the Smiths Medical Division, a division of Smiths Group Plc, to strengthen its infusion therapy product range and enter new clinical care markets.

Elastomeric Infusion Pumps Market Report Scope

Global Elastomeric Infusion Pumps Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global elastomeric infusion pumps market report based on product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Continuous Rate Elastomeric Infusion Pumps

  • Variable Rate Elastomeric Infusion Pumps

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Pain Management

  • Chemotherapy

  • Antibiotic/Antiviral Therapy

  • Others

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Ambulatory Surgical Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait